


|
Gastrointestinal Pathology
Sunday, February 27, 2011, 7:30 PM
CC BRA




Clinical histories are printed below.
Click on the case numbers for text and references of each case.
Click on each slide thumbnail image for an enlarged view



|
Moderator:
|
GREGORY Y. LAUWERS
Massachusetts General Hospital
Boston, MA
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. The speakers listed below have indicated they have nothing to disclose.
|
|
Panelists:
|
Amitabh Srivastava, Dartmouth Hitchcock Medical Center, Lebanon, NH
David Driman, London Health Sciences Centre, London, Ontario, Canada
Priyanthi Kumarasinghe, PathWest, Queen Elizabeth II Medical Centre, Perth, Australia
Noam Harpaz, The Mount Sinai Medical Center, New York, NY
Robert D. Odze, Brigham and Women Hospital, Boston, MA
|



Clinical Histories and Still Images are displayed below.
Click on slide thumbnail images for an enlarged view.

If you have any difficulties viewing these slides, email or call George Clay at +1.724.449.1137.




for Text and References

Submitted by: Amitabh Srivastava -


A 65 year old man presented with abdominal pain, anemia and an unintentional 15 lb weight loss over the past six months. Colonoscopy revealed two small polyps but no evidence of malignancy. Upper GI endoscopy showed an ulcer with heaped up margins in the distal stomach. Biopsies from the lesion showed high-grade dysplasia and intramucosal adenocarcinoma. However, endoscopic ultrasound examination was consistent with a T2 lesion and a distal gastrectomy was performed.




for Text and References

Submitted by: David Kevin Driman -


This 31 year old male presented with a one month history of profuse watery diarrhea and vomiting. He had had a heart transplant 2 years previously for familial dilated cardiomyopathy. Routine blood work was normal and his stools contained no ova or parasites. He was taking the following medication: tacrolimus, mycophenolate mofetil, aspirin, lansoprazole, atorvastatin and buproprion. Colonoscopy showed patchy erythema but there were no ulcers or other striking abnormalities. Several biopsies were taken.

 Case 2 - Slide 1
|

 Case 2 - Figure 1 Patchy crypt architectural distortion, variable inflammation and scattered dilated crypts |
 Case 2 - Figure 2 Dilated crypts containing neutrophils and cell debris; some crypts lined by hypereosinophilic epithelium with a regenerative apparance |
 Case 2 - Figure 3 Increased lamina propria eosinophils, damaged crypt filled with neutrophils; other crypts showing reactive changes with hypermucinous epithelium |
 Case 2 - Figure 4 Crypt epithelial apoptosis |
 Case 2 - Figure 5 IBD type appearance with lamina propria edema and crypt architectural abnormalities |
 Case 2 - Figure 6 Crypt distortion and branching |
 Case 2 - Figure 7 Crypt distortion and loss in association with small dilated damaged crypts |
 Case 2 - Figure 8 Small damaged crypts; one lined by hypereosinophilic regenerative type epithelium, the other dilated and lined by atrophic thinned epithelium |



for Text and References

Submitted by: Priyanthi Kumarasinghe -


A 65 year old male underwent a total gastrectomy. A previous endoscopic biopsy showed a poorly differentiated adenocarcinoma. Her-2 status was assessed.

 Case 3 - Figure 5 HER-2 protein expression of the area shown in figure 3 demonstrating marked heterogeneity
|
 Case 3 - Figure 6 HER2 immunohistochemical expression of the dysplastic epithelium and invasive carcinoma in contrast to the negative non-neoplastic tissue
|
 Case 3 - Figure 7 HER-2 protein expression in the area shown in figure 2 that includes dysplastic and invasive areas
|
 Case 3 - Figure 8 HER-2 protein expression, scored as 3+ according to Hoffman et al
|
 Case 3 - Figure 9 HER-2 protein expression in vascular emboli
|
 Case 3 - Figure 10 HER-2 gene amplification with Silver In- Situ Hybridisation (SISH); tumour cells show high amplification
|



for Text and References

Submitted by: Noam Harpaz -


The patient was a 50-year-old male who presented with pain of the left upper extremity. He had been diagnosed with a rectal tumor 5 years earlier at another facility and treated with chemotherapy and local radiation. Radiological examination now revealed a large lytic tumor in the left humerus and further work-up revaled hepatic, pulmonary and intracranial lesions. A biopsy of the humeral tumor was performed and a slide of the original rectal biopsy was retrieved for comparison.

 Case 4 - Figure 1 Dyscohesive tumors cells with peripherally displaced nuclei. Inset: Biopsy tissue from lytic tumor of humerus |
 Case 4 - Figure 2 Signet ring features, nuclear atypia and paranuclear zone at higher magnification |
 Case 4 - Figure 3 Negative stains for DPAS, HMB45, CD45 and lambda light chain |
 Case 4 - Figure 4 Cytoplasmic staining for AE1/AE3. The cytoplasmic staining is heterogeneous and occasionally globular |
 Case 4 - Figure 9
|
 Case 4 - Figure 10 Earlier rectal biopsy demonstrates invasive tumor arranged in irregular cords and single cells. |
 Case 4 - Figure 11 Despite some crush artifact, similarity of the rectal tumor cells to those of the bone tumor is evident at high magnification. |
 Case 4 - Figure 12 Second case of rectal signet ring neuroendocrine carcinoma. The tumor presented endoscopically as a 7cm rectal mass. |
 Case 4 - Figure 13 Rectal biopsy shows the mucosa infiltrated by dyscohesive signet ring cells |
 Case 4 - Figure 14 Negative stains for mucicarmine and BRST2 and positive stains for CAM5.2 and synaptophysin. |



for Text and References

Submitted by: Robert D. Odze -


The case represents a 56 year old male with an 8 year history of Barrett's esophagus (BE). At initial diagnosis, the patient had long segment BE extending to 5 cm above the gastroesophageal junction (GEJ). At the time of the patient's most recent endoscopic surveillance, the length of esophageal columnar mucosa was 3.5 cm, and there were multiple foci of squamous islands. Four quadrant biopsies were obtained from every 2 cm of columnar-lined esophagus. No other endoscopic abnormalities were detected. The biopsy of interest represents mucosa obtained from 2 cm proximal to the GEJ. The patient has no family history of esophageal or colon cancer, and other biopsies from the upper GI tract (stomach and duodenum) were within normal limits.

|

Handouts for all Specialty Conferences will be accessible via the
"Educational Materials" section on the homepage the morning after each respective conference. Printed
copies of the handout will not be available at the meeting.
|
|
|